Skip to main content

Peer Review reports

From: Thyroid-stimulating hormone decreases the risk of osteoporosis by regulating osteoblast proliferation and differentiation

Original Submission
22 Jul 2020 Submitted Original manuscript
3 Sep 2020 Author responded Author comments - Tuo Deng
Resubmission - Version 2
3 Sep 2020 Submitted Manuscript version 2
26 Sep 2020 Author responded Author comments - Tuo Deng
Resubmission - Version 3
26 Sep 2020 Submitted Manuscript version 3
21 Oct 2020 Author responded Author comments - Tuo Deng
Resubmission - Version 4
21 Oct 2020 Submitted Manuscript version 4
24 Oct 2020 Reviewed Reviewer Report
13 Nov 2020 Reviewed Reviewer Report
26 Nov 2020 Author responded Author comments - Tuo Deng
Resubmission - Version 5
26 Nov 2020 Submitted Manuscript version 5
30 Dec 2020 Author responded Author comments - Tuo Deng
Resubmission - Version 6
30 Dec 2020 Submitted Manuscript version 6
13 Jan 2021 Author responded Author comments - Tuo Deng
Resubmission - Version 7
13 Jan 2021 Submitted Manuscript version 7
7 Feb 2021 Author responded Author comments - Tuo Deng
Resubmission - Version 8
7 Feb 2021 Submitted Manuscript version 8
19 Feb 2021 Author responded Author comments - Tuo Deng
Resubmission - Version 9
19 Feb 2021 Submitted Manuscript version 9
1 Mar 2021 Author responded Author comments - Tuo Deng
Resubmission - Version 10
1 Mar 2021 Submitted Manuscript version 10
Publishing
3 Mar 2021 Editorially accepted
16 Mar 2021 Article published 10.1186/s12902-021-00715-8

You can find further information about peer review here.

Back to article page